Items where Author is "Wheeler, GN"
Group by: Item Type | No Grouping
Number of items: 2.
    Alhashmi, M, Gremida, AME, Maharana, SK, Antonaci, M  ORCID: 0000-0002-5255-465X, Kerr, A, Fu, S, Lunn, S, Turner, DA, Al-Maslamani, NA, Liu, K, Meschis, MM, Sutherland, H, Wilson, P, Clegg, P, Wheeler, GN, van 't Hof, RJ, Bou-Gharios, G and Yamamoto, K
ORCID: 0000-0002-5255-465X, Kerr, A, Fu, S, Lunn, S, Turner, DA, Al-Maslamani, NA, Liu, K, Meschis, MM, Sutherland, H, Wilson, P, Clegg, P, Wheeler, GN, van 't Hof, RJ, Bou-Gharios, G and Yamamoto, K  ORCID: 0000-0002-8481-775X
  
(2025)
Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.
    Bone Research, 13.
    
     ISSN 2095-4700
ORCID: 0000-0002-8481-775X
  
(2025)
Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.
    Bone Research, 13.
    
     ISSN 2095-4700
  
  
Hanson, K, Robinson, SR, Al-Yousuf, K, Hendry, AE, Sexton, DW, Sherwood, V and Wheeler, GN (2017) The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth. Oncotarget, 9 (3). ISSN 1949-2553
 
            ![[up]](/style/images/multi_up.png) Up a level
 Up a level